COMMUNIQUÉS West-GlobeNewswire

Organic & Natural Health Association Honors SENPA’s Debra Short with Champion Award at Conference Shaping Policy, and the Future of Retail
05/02/2026
FT. LAUDERDALE, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Organic & Natural Health Association ’s 11th annual conference, “The United States of Health: Building Bridges to Opportunity,” concluded Jan. 22 with a [...]
Guerbet : Chiffre d’affaires 2025.
05/02/2026
Chiffre d’affaires 2025 Chiffre d’affaires annuel : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , largement dû à la baisse de l’activité en France Au quatrième trimestre, une baisse de 5,6% à TCC [...]
Guerbet : 2025 revenue.
05/02/2026
2025 revenue Full-year revenue: €786.4 million, down 3.5% at CER 1 and on a like-for-like basis 2 , largely due to the fall in business in France A decline in Q4 of 5.6% at CER and on a like-for-like basis, linked to [...]
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05/02/2026
BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit
05/02/2026
BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026
05/02/2026
ORANGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its fourth quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026, after market close. Following [...]
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY
05/02/2026
Strategic Restructuring Eliminates Expenses Not Essential to the Phase 3 Study Khursheed Anwer, Ph.D., Executive Vice President and Chief Scientific Officer, will retire after nearly 12 years at the company Phase 3 [...]
Proven Senior Care Model Takes Center Stage at the Capitol
05/02/2026
InnovAge PACE leaders and participants meet with lawmakers during critical budget year DENVER, Feb. 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leading Program of All-Inclusive [...]
Polaryx Therapeutics Welcomes New Members of the Board of Directors
05/02/2026
PARAMUS, NJ, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics , Inc. (Nasdaq: PLYX ) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease- [...]
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
05/02/2026
Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market LITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS [...]
Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
05/02/2026
New digital health platform being launched in partnership with UCSD allows remote physician-monitored neurotherapy subscription models to expand reach, lower cost, and break down treatment stigma for brain-health [...]
ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call
05/02/2026
SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter [...]
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
05/02/2026
Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. ( Nasdaq: HSCS; HSCSW ) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing electrocardiography (“ECG” or [...]
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
05/02/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and [...]
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
05/02/2026
Year-end report discusses combination therapy’s Mechanism of Action activating both innate and adaptive immune responses OCALA, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or [...]
Alumis to Participate in Upcoming February Investor Conferences
05/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today [...]
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
05/02/2026
Appointment Strengthens RenovoRx’s C-Suite Leadership to Support Commercial Growth of RenovoCath® MOUNTAIN VIEW, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a [...]
Basic Jane Advances Science-Led Cannabinoid Platform Focused on Senior Care and Scalable Product Formats
05/02/2026
SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Basic Jane, a consumer product–focused subsidiary of Verda Bio, today highlighted its evolution from a mission-driven CBD brand into a scalable, partner-ready cannabinoid [...]
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
05/02/2026
HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]

Pages